Quantcast

Latest kidney diseases Stories

2014-01-28 12:30:02

The CKD Market Will Decline Through 2017, Due to Genericization of Expensive Agents and Reimbursement Constraints in the U.S., According to Findings from Decision Resources Group BURLINGTON, Mass., Jan. 28, 2014 /PRNewswire/ -- Decision Resources Group finds that, after an initial decline driven by generic and biosimilar competition in the G7 markets and changes in reimbursement practices in the United States, the total chronic kidney disease (CKD) market will return to growth, achieving...

2014-01-21 16:25:38

NEW YORK, Jan. 21, 2014 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that it has commenced a $90 million underwritten public offering of shares of its common stock. In connection with this offering, Keryx expects to grant to the underwriters a 30-day option to purchase additional shares of common stock, equal to up to 15% of the number of shares of common stock sold in the offering. J.P. Morgan is acting as the sole book-running manager in the...

2014-01-16 04:20:40

GLENDALE, Calif., Jan. 16, 2014 /PRNewswire-USNewswire/ -- Prom season comes early for hundreds of teens and young adults (14 to 24 years old) who have kidney disease, who are on dialysis or who have had a transplant. Renal Support Network (RSN) steps out onto the dance floor Sunday, January 19, 2014, to host the 15(th) Annual Renal Teen Prom for these teens and their guests. Last week attendees and guests took their pick of evening gowns that were donated especially for the event. This...

2014-01-13 04:20:59

STOCKHOLM, January 13, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces it has completed recruitment of patients into a Phase IIb NEFIGAN study of its orphan drug product, Nefecon(R) (http://www.nefigan.net). Pharmalink expects to announce top-line results in mid-2015. The Phase IIb study is a multi-center, randomized, double-blinded placebo-controlled clinical trial designed to assess the efficacy and safety...

2014-01-10 16:21:55

DUBLIN, January 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/j635wj/nephrology_and) has announced the addition of the "2013 Report on the International Nephrology and Urology Devices Market - Industry Analysis, Size, Share, Trends and Forecast to 2018" [http://www.researchandmarkets.com/research/j635wj/nephrology_and ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )...

2014-01-10 11:26:19

A single dose of lithium helped restore kidney function in mice with acute kidney injury A mood stabilizer used to treat bipolar affective disorders may also help treat acute kidney injury, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings are significant because there are no effective therapies for AKI. AKI, an abrupt decline in kidney function, is an increasingly prevalent and potentially serious condition...

2014-01-10 08:23:12

Earns $5.75M Milestone from AstraZeneca for Asthma Partnership SOUTH SAN FRANCISCO, Calif., Jan. 10, 2014 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, will present updated product development plans and a financial update at the upcoming 32(nd) Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 16th at 9:00 a.m. PT (see webcast details below)....

2014-01-08 04:21:14

STOCKHOLM, January 8, 2014 /PRNewswire/ -- OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease. "We are happy to announce that we have initiated our confirmatory...

2013-12-21 23:02:17

Kidney Disease Solution is the latest treatment program for those with kidney disease. A full Kidney Disease Solution review on the site hynguyenblog.com shows whether this program is helpful or not. (PRWEB) December 21, 2013 Kidney Disease Solution is a new natural method that is designed by Duncan Capicchiano who claims to help people treat the kidney disease permanently. The natural method provides users with safe tips, which show them how to reduce creatinine levels, how to improve...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related